SCHEMBL15328673

SCHEMBL15328673

C=C(C)c1cc(N2CCOCC2)cc(C)c1C(=O)NCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.45
GAA P10253 1/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 1/20 0.43
SRPK1 Q96SB4 1/20 0.42
KLKB1 P03952 1/20 0.42
KLK1 P06870 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
EGFR P00533 1/20 0.42
CDK2 P24941 1/20 0.42
NAMPT P43490 1/20 0.42
EPHX2 P34913 1/20 0.41
MTTP P55157 1/20 0.41
PPARG P37231 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
THRB P10828 1/20 0.41
AKR1C3 P42330 1/20 0.40
CD274 Q9NZQ7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15328663 0.90 TP53 (0.48) GAALMNAMAPTKLKB1KLK1
SCHEMBL15328209 0.88 KMT2A (0.47) LMNAMAPTKLKB1KLK1EGFR
SCHEMBL15328525 0.84 BRAF (0.45) BRAFGAALMNAMAPTSRPK1
SCHEMBL15328121 0.83 BRAF (0.45) BRAFGAALMNAMAPTSRPK1
SCHEMBL15328232 0.79 PPARG (0.46) LMNAMAPTKLKB1KLK1NAMPT
SCHEMBL15328274 0.78 PPARG (0.48) LMNAKLKB1KLK1HDAC1HDAC6
SCHEMBL15328664 0.75 GAA (0.52) GAALMNAKLKB1KLK1NAMPT
SCHEMBL2129798 0.75 KCNQ3 (0.50) BRAFGAALMNAMAPTALDH1A1
SCHEMBL2130908 0.75 BRAF (0.48) BRAFGAALMNAMAPT
SCHEMBL30795518 0.75 BRAF (0.48) BRAFGAALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US claimed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US claimed
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US disclosed
EP-2844645-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-03-11 EP disclosed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US disclosed
WO-2013156155-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS KCNJ2, KCNQ2, KCNQ1 BRAF 2639/4885GAA 3329/4885LMNA 1359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.